Related Experiment Video

Updated: May 2, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

5.7K

Phosphatase of regenerating liver: a novel target for cancer therapy

Amanda M Campbell1, Zhong-Yin Zhang

  • 1Indiana University School of Medicine, Department of Biochemistry and Molecular Biology , John D. Van Nuys Medical Science Building, Room 4053A, 635 Barnhill Drive, Indianapolis, IN 46202-5126 , USA.

Expert Opinion on Therapeutic Targets
|March 4, 2014
PubMed
Abstract

Insights

Phosphatases of regenerating livers (PRLs) are promising cancer drug targets. Inhibiting these oncogenes may combat cancer metastasis and signaling pathway disruptions.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Phosphatases of regenerating livers (PRLs) are identified as novel oncogenes.
  • PRLs are implicated in deregulated cell signaling pathways frequently observed in cancer.
  • Overexpression of PRLs is a known driver of cancer metastasis.

Purpose of the Study:

  • To review the discovery and characteristics of the PRL family.
  • To summarize the role of PRLs in cancer, cellular functions, and signaling.
  • To discuss the potential of PRLs as drug targets and current inhibition strategies.

Main Methods:

  • Literature review covering PRL discovery and characteristics.
  • Analysis of studies on PRLs' role in cancer and cell signaling.
  • Discussion of drug development strategies for PRL inhibition.

Main Results:

  • PRLs interact with key cancer-related signaling pathways like Src/ERK1/2 and PTEN/PI3K/Akt.
  • Upregulation of PRLs is directly linked to the promotion of cancer metastasis.
  • PRLs demonstrate significant potential as therapeutic targets in oncology.

Conclusions:

  • PRLs represent promising targets for novel anticancer therapeutics.
  • Further research is essential to elucidate PRL function in normal and cancerous tissues.
  • Integrated approaches are required to identify PRL substrates and validate druggability for therapeutic development.

More Related Videos

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

856
A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors10:17

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors

Published on: April 29, 2022

1.8K

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
12.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.4K
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K